Our Services
Medical Information
Helpful Resources
Published on: 4/4/2026
Farxiga side effects and kidney protection in brief: common effects include genital yeast infections, urinary tract infections, increased urination, and mild dehydration; rare but serious risks include diabetic ketoacidosis, acute kidney injury, and the very rare infection called Fournier’s gangrene.
For kidney protection, large trials such as DAPA-CKD show about a 39% reduction in the composite of worsening kidney function, kidney failure, or death from kidney or heart causes, with slower eGFR decline and benefits even without diabetes. There are several factors to consider, including monitoring, hydration, interacting meds, and when to seek urgent care; see the complete answer below for details that could influence your next steps.
Farxiga (dapagliflozin) is a prescription medication used to treat type 2 diabetes, chronic kidney disease (CKD), and certain types of heart failure. It belongs to a class of drugs called SGLT2 inhibitors. These medications work by helping your kidneys remove excess sugar from the bloodstream through urine.
If you've been prescribed Farxiga—or are considering it—you may be wondering about Farxiga side effects and how well it actually protects the kidneys. Below is a clear, balanced overview based on large clinical trials and prescribing data.
Farxiga blocks a protein in the kidneys called SGLT2 (sodium-glucose cotransporter-2). This protein normally helps reabsorb glucose back into the bloodstream. By blocking it, Farxiga allows excess sugar to leave the body in urine.
This leads to:
Like all medications, Farxiga has potential side effects. Most are mild and manageable, but some can be serious.
The most frequently reported Farxiga side effects include:
Because Farxiga increases sugar in the urine, it creates an environment where yeast can grow more easily.
Symptoms may include:
These infections are more common in women but can also affect men. They are usually treatable with antifungal medications.
Some patients experience:
Most UTIs are mild, but if you develop fever, back pain, or chills, seek medical care promptly.
Because the drug removes sugar through urine, you may:
This is expected and often improves over time.
Farxiga has a mild diuretic effect. In some people, especially older adults, this can cause:
Staying hydrated is important.
While rare, some side effects require immediate attention.
This is a serious condition where the body produces high levels of ketones. What makes it unusual with Farxiga is that it can happen even if blood sugar isn't extremely high.
Symptoms may include:
DKA is a medical emergency. Seek urgent care if these symptoms appear.
Although Farxiga protects the kidneys long term, in rare cases it may cause temporary kidney stress, particularly if:
Doctors usually monitor kidney function with blood tests before and during treatment.
This is a rare but serious infection of the genital area. It requires emergency treatment. Symptoms include:
This complication is extremely uncommon, but it is important to be aware of it.
Farxiga is not just a diabetes drug. It is FDA-approved to reduce the risk of kidney function decline, kidney failure, and cardiovascular death in adults with chronic kidney disease.
The most important study supporting this is the DAPA-CKD trial.
This large clinical trial studied patients with chronic kidney disease—with and without diabetes.
Key findings:
This was a major breakthrough because kidney disease often progresses silently over time.
Farxiga helps the kidneys in several ways:
Unlike some older diabetes medications, Farxiga does more than just lower blood sugar—it directly supports kidney health.
In addition to kidney protection, Farxiga also reduces:
The DECLARE-TIMI 58 trial, which included over 17,000 patients, showed significant reductions in heart failure hospitalization.
For many patients with diabetes, kidney disease, or heart disease, these added benefits are important.
Farxiga may not be appropriate if you:
Your doctor will assess your kidney function before prescribing it.
To reduce risks and monitor for Farxiga side effects, doctors typically check:
Most side effects are manageable when caught early.
Seek medical care right away if you experience:
Any potentially life-threatening symptom should be evaluated promptly.
Always speak to a doctor if something feels wrong.
If you're concerned about blood sugar management or experiencing symptoms that might be related to Diabetes Mellitus, it's important to get properly evaluated so you can understand your condition and explore all available treatment options.
A free AI-powered symptom checker can help you identify potential warning signs and prepare meaningful questions before your next medical appointment.
When evaluating Farxiga side effects, it's important to look at the full picture.
For many patients, the protective kidney and heart benefits outweigh the risks. However, every patient is different.
Farxiga (dapagliflozin) is more than a blood sugar medication. Clinical trials show strong evidence that it slows kidney disease progression and reduces heart complications in high-risk individuals.
Most Farxiga side effects are mild and manageable, especially with good hydration and hygiene. Serious side effects are rare but require immediate medical attention.
If you are taking Farxiga—or considering it—have an open discussion with your healthcare provider about:
Never ignore symptoms that feel severe or unusual. Always speak to a doctor about anything that could be serious or life-threatening.
With proper monitoring and communication, Farxiga can be a powerful tool in managing diabetes, protecting kidney function, and improving long-term health outcomes.
(References)
* McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020 Oct 8;383(23):2219-2229. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24. PMID: 32971212.
* Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019 Jul 4;381(1):15-26. doi: 10.1056/NEJMoa1812385. Epub 2019 Jun 9. PMID: 31180193.
* Heerspink HJL, Stefansson B, Correa-Rotter R, et al. Dapagliflozin in Patients with Type 2 Diabetes and Chronic Kidney Disease. N Engl J Med. 2020 May 29;383(1):331-341. doi: 10.1056/NEJMoa1911420. PMID: 32442111.
* Nauck MA, Del Prato S, Meier JJ, et al. Safety and Tolerability of Dapagliflozin in Patients With Type 2 Diabetes Mellitus: A Review of Clinical Trials. Adv Ther. 2019 Jun;36(6):1283-1300. doi: 10.1007/s12325-019-00940-0. Epub 2019 May 3. PMID: 31057866.
* Jhund PS, Abraham WT, Docherty KF, et al. Renal outcomes with dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the DELIVER trial. Eur Heart J. 2023 Feb 1;44(5):440-452. doi: 10.1093/eurheartj/ehac699. PMID: 36453733.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.